FDA Awards Breakthrough Device Designation to Elon Musk’s Neuralink Device, Blindsight
Elon Musk’s Neuralink, a startup focused on developing brain-computer interfaces (BCIs), has recently been granted FDA Breakthrough Device Designation for its new product, Blindsight. Blindsight is an innovative implant designed to restore vision for individuals who are blind, targeting the visual cortex in the brain. The core function of Blindsight involves implanting a microelectrode array […]